Filing Details
- Accession Number:
- 0001214659-21-012712
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-12-03 20:09:18
- Reporting Period:
- 2021-12-03
- Accepted Time:
- 2021-12-03 20:09:18
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1576263 | Mirati Therapeutics Inc. | MRTX | Pharmaceutical Preparations (2834) | 462693615 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1579824 | M Charles Baum | C/O Mirati Therapeutics Inc. 3545 Cray Court San Diego CA 92121 | President & Head Of R&D | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-12-03 | 47,204 | $8.49 | 159,918 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-12-03 | 9,200 | $131.61 | 150,718 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-12-03 | 21,509 | $132.49 | 129,209 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-12-03 | 3,900 | $133.27 | 125,309 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-12-03 | 3,842 | $134.57 | 121,467 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-12-03 | 6,558 | $135.64 | 114,909 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-12-03 | 1,210 | $136.66 | 113,699 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-12-03 | 985 | $137.56 | 112,714 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2021-12-03 | 47,204 | $0.00 | 47,204 | $8.49 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2017-05-09 | 2022-11-12 | No | 4 | M | Direct |
Footnotes
- The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 10, 2020.
- This transaction was executed in multiple trades at prices ranging from $131.07 to $132.06. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $132.07 to $133.06. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $133.07 to $134.02. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $134.15 to $135.10. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $135.15 to $136.135. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $136.29 to $137.16. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $137.34 to $137.65. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Billionaire Hedge Funds
